M. Wuhrer

发表

A robust nanoscale RP HPLC-MS approach for sensitive Fc proteoform profiling of IgG allotypes.

C. Gstöttner, E. Domínguez-Vega, C. Blöchl, 2023, Analytica chimica acta.

(Sialyl)Lewis Antigen Expression on Glycosphingolipids, N-, and O-Glycans in Colorectal Cancer Cell Lines is Linked to a Colon-Like Differentiation Program

O. Mayboroda, Di Wang, G. Lageveen-Kammeijer, 2024, Molecular & cellular proteomics : MCP.

Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions

D. Tuveson, S. V. van Vliet, M. Bijlsma, 2024, Communications biology.

Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise

P. Heeringa, D. Falck, C. Stegeman, 2023, Frontiers in immunology.

The Human Blood N-Glycome: Unraveling Disease Glycosylation Patterns

O. Mayboroda, T. Pongracz, Tamas Pongracz, 2024, JACS Au.

Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases

L. Trouw, S. Nicolardi, B. van Hoek, 2024, Journal of translational medicine.

Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2

V. Temchura, Kaveh Roshanbinfar, Leila Issmail, 2024, Communications biology.

Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity in COVID-19 disease

J. Goeman, M. Feltkamp, L. Trouw, 2024, Scientific reports.

Total plasma N-glycomic signature of SARS-CoV-2 infection

M. Bladergroen, T. Pongracz, S. Arbous, 2024, iScience.

IgG1 glycosylation highlights premature aging in Down syndrome

G. Vidarsson, J. Nouta, R. Visser, 2024, Aging cell.

GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC-MS readout.

D. Falck, M. Wuhrer, 2024, Nature protocols.

IgG glycosylation associates with risk of progression from latent to active tuberculosis.

Julie G. Burel, Wenjun Wang, Martin Dedicoat, 2024, The Journal of infection.

N-linked Fc glycosylation is not required for IgG-B-cell receptor function in a GC-derived B-cell line

G. Vidarsson, A. Bentlage, C. Koeleman, 2024, Nature communications.

Assessment of IgG‐Fc glycosylation from individual RhD‐specific B cell clones reveals regulation at clonal rather than clonotypic level

G. Vidarsson, C. Koeleman, R. Visser, 2023, Immunology.

Cellular surface plasmon resonance-based detection of anti-HPA-1a antibody glycosylation in fetal and neonatal alloimmune thrombocytopenia

G. Vidarsson, A. Bentlage, R. Visser, 2023, Frontiers in immunology.

Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccination.

J. Nouta, S. Lehrian, T. Pongracz, 2024, Allergy.

A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes

J. Schwenk, D. Mook-Kanamori, N. Friedrich, 2024, Nature communications.

Non-prime- and Prime-side Profiling of Pro-Pro Endopeptidase Specificity Using Synthetic Combinatorial Peptide Libraries and Mass Spectrometry

P. V. van Veelen, P. Hensbergen, R. Cordfunke, 2024, bioRxiv.

Benchmarking glycoform-resolved affinity separation – mass spectrometry assays for studying FcγRIIIa binding

D. Falck, C. Gstöttner, Markus Haberger, 2024, Frontiers in immunology.

Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes

L. T. ’t Hart, A. Lieverse, R. Slieker, 2024, International journal of molecular sciences.